231 related articles for article (PubMed ID: 22985900)
1. Brain networks predicting placebo analgesia in a clinical trial for chronic back pain.
Hashmi JA; Baria AT; Baliki MN; Huang L; Schnitzer TJ; Apkarian VA
Pain; 2012 Dec; 153(12):2393-2402. PubMed ID: 22985900
[TBL] [Abstract][Full Text] [Related]
2. Lidocaine patch (5%) is no more potent than placebo in treating chronic back pain when tested in a randomised double blind placebo controlled brain imaging study.
Hashmi JA; Baliki MN; Huang L; Parks EL; Chanda ML; Schnitzer T; Apkarian AV
Mol Pain; 2012 Apr; 8():29. PubMed ID: 22531485
[TBL] [Abstract][Full Text] [Related]
3. Effects of open-label placebo on pain, functional disability, and spine mobility in patients with chronic back pain: a randomized controlled trial.
Kleine-Borgmann J; Schmidt K; Hellmann A; Bingel U
Pain; 2019 Dec; 160(12):2891-2897. PubMed ID: 31479068
[TBL] [Abstract][Full Text] [Related]
4. Smoking increases risk of pain chronification through shared corticostriatal circuitry.
Petre B; Torbey S; Griffith JW; De Oliveira G; Herrmann K; Mansour A; Baria AT; Baliki MN; Schnitzer TJ; Apkarian AV
Hum Brain Mapp; 2015 Feb; 36(2):683-94. PubMed ID: 25307796
[TBL] [Abstract][Full Text] [Related]
5. Reorganization of hippocampal functional connectivity with transition to chronic back pain.
Mutso AA; Petre B; Huang L; Baliki MN; Torbey S; Herrmann KM; Schnitzer TJ; Apkarian AV
J Neurophysiol; 2014 Mar; 111(5):1065-76. PubMed ID: 24335219
[TBL] [Abstract][Full Text] [Related]
6. Effect of Pain Reprocessing Therapy vs Placebo and Usual Care for Patients With Chronic Back Pain: A Randomized Clinical Trial.
Ashar YK; Gordon A; Schubiner H; Uipi C; Knight K; Anderson Z; Carlisle J; Polisky L; Geuter S; Flood TF; Kragel PA; Dimidjian S; Lumley MA; Wager TD
JAMA Psychiatry; 2022 Jan; 79(1):13-23. PubMed ID: 34586357
[TBL] [Abstract][Full Text] [Related]
7. Cannabis analgesia in chronic neuropathic pain is associated with altered brain connectivity.
Weizman L; Dayan L; Brill S; Nahman-Averbuch H; Hendler T; Jacob G; Sharon H
Neurology; 2018 Oct; 91(14):e1285-e1294. PubMed ID: 30185448
[TBL] [Abstract][Full Text] [Related]
8. Risky monetary behavior in chronic back pain is associated with altered modular connectivity of the nucleus accumbens.
Berger SE; Baria AT; Baliki MN; Mansour A; Herrmann KM; Torbey S; Huang L; Parks EL; Schnizter TJ; Apkarian AV
BMC Res Notes; 2014 Oct; 7():739. PubMed ID: 25331931
[TBL] [Abstract][Full Text] [Related]
9. Chronic pain and the emotional brain: specific brain activity associated with spontaneous fluctuations of intensity of chronic back pain.
Baliki MN; Chialvo DR; Geha PY; Levy RM; Harden RN; Parrish TB; Apkarian AV
J Neurosci; 2006 Nov; 26(47):12165-73. PubMed ID: 17122041
[TBL] [Abstract][Full Text] [Related]
10. A preliminary fMRI study of analgesic treatment in chronic back pain and knee osteoarthritis.
Baliki MN; Geha PY; Jabakhanji R; Harden N; Schnitzer TJ; Apkarian AV
Mol Pain; 2008 Oct; 4():47. PubMed ID: 18950528
[TBL] [Abstract][Full Text] [Related]
11. Brain Connectivity Predicts Placebo Response across Chronic Pain Clinical Trials.
Tétreault P; Mansour A; Vachon-Presseau E; Schnitzer TJ; Apkarian AV; Baliki MN
PLoS Biol; 2016 Oct; 14(10):e1002570. PubMed ID: 27788130
[TBL] [Abstract][Full Text] [Related]
12. Pregabalin rectifies aberrant brain chemistry, connectivity, and functional response in chronic pain patients.
Harris RE; Napadow V; Huggins JP; Pauer L; Kim J; Hampson J; Sundgren PC; Foerster B; Petrou M; Schmidt-Wilcke T; Clauw DJ
Anesthesiology; 2013 Dec; 119(6):1453-64. PubMed ID: 24343290
[TBL] [Abstract][Full Text] [Related]
13. Placebo conditioning and placebo analgesia modulate a common brain network during pain anticipation and perception.
Watson A; El-Deredy W; Iannetti GD; Lloyd D; Tracey I; Vogt BA; Nadeau V; Jones AK
Pain; 2009 Sep; 145(1-2):24-30. PubMed ID: 19523766
[TBL] [Abstract][Full Text] [Related]
14. Predicting individual differences in placebo analgesia: contributions of brain activity during anticipation and pain experience.
Wager TD; Atlas LY; Leotti LA; Rilling JK
J Neurosci; 2011 Jan; 31(2):439-52. PubMed ID: 21228154
[TBL] [Abstract][Full Text] [Related]
15. Functional brain interactions that serve cognitive-affective processing during pain and placebo analgesia.
Craggs JG; Price DD; Verne GN; Perlstein WM; Robinson MM
Neuroimage; 2007 Dec; 38(4):720-9. PubMed ID: 17904390
[TBL] [Abstract][Full Text] [Related]
16. Placebo-induced pain reduction is associated with negative coupling between brain networks at rest.
Wagner IC; Rütgen M; Hummer A; Windischberger C; Lamm C
Neuroimage; 2020 Oct; 219():117024. PubMed ID: 32512124
[TBL] [Abstract][Full Text] [Related]
17. Loss of nucleus accumbens low-frequency fluctuations is a signature of chronic pain.
Makary MM; Polosecki P; Cecchi GA; DeAraujo IE; Barron DS; Constable TR; Whang PG; Thomas DA; Mowafi H; Small DM; Geha P
Proc Natl Acad Sci U S A; 2020 May; 117(18):10015-10023. PubMed ID: 32312809
[TBL] [Abstract][Full Text] [Related]
18. Corticolimbic anatomical characteristics predetermine risk for chronic pain.
Vachon-Presseau E; Tétreault P; Petre B; Huang L; Berger SE; Torbey S; Baria AT; Mansour AR; Hashmi JA; Griffith JW; Comasco E; Schnitzer TJ; Baliki MN; Apkarian AV
Brain; 2016 Jul; 139(Pt 7):1958-70. PubMed ID: 27190016
[TBL] [Abstract][Full Text] [Related]
19. Effect of propofol anesthesia on resting state brain functional connectivity in Indian population with chronic back pain.
Sriganesh K; Balachandar R; Bagepally BS; Saini J; Umamaheswara Rao GS
Neurol India; 2017; 65(2):286-292. PubMed ID: 28290391
[TBL] [Abstract][Full Text] [Related]
20. Efficacy, Safety, and Tolerability of Fulranumab as an Adjunctive Therapy in Patients With Inadequately Controlled, Moderate-to-Severe Chronic Low Back Pain: A Randomized, Double-blind, Placebo-controlled, Dose-ranging, Dose-loading Phase II Study.
Sanga P; Polverejan E; Wang S; Kelly KM; Thipphawong J
Clin Ther; 2016 Jun; 38(6):1435-1450. PubMed ID: 27101815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
